Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Séverine Vermeire1 Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium, [email protected]Correspondence[email protected]

François D’heygere2 Department of Gastroenterology, AZ Groeninge, Kortrijk, Belgium

Antoine Nakad3 Department of Gastroenterology, CHWAPI, Tournai, Belgium

Denis Franchimont4 Department of Gastroenterology, Erasme Hospital, Brussels, Belgium

Fernand Fontaine5 Department of Gastroenterology, CHC St Joseph, Liège, Belgium

Edouard Louis6 Department of Gastroenterology, University Hospital CHU Sart Tilman, Liège, Belgium

Philippe Van Hootegem7 Department of Gastroenterology, AZ St Lucas, Brugge, Belgium

Olivier Dewit8 Department of Gastroenterology, UCL St Luc, Brussels, Belgium

Guy Lambrecht9 Department of Gastroenterology, AZ Damiaan, Oostende, Belgium

Beatrijs Strubbe10 Department of Gastroenterology, OLV Hospital, Aalst, Belgium

Filip Baert11 Department of Gastroenterology, AZ Delta, Roeselare-Menen, Belgium

Your download is now in progress and you may close this window